Wednesday, September 14, 2016 12:08:43 PM
Recent LXRX News
- Lexicon Pharmaceuticals Announces Departure of President and Chief Operating Officer • GlobeNewswire Inc. • 09/16/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/16/2024 10:51:46 AM
- New Secondary Analysis of Phase 3 Data Demonstrates Sotagliflozin Improves Time-In-Range (TIR) and Several Parameters of Glucose Control and Variability in Basal Insulin-Treated Type 2 Diabetes • GlobeNewswire Inc. • 09/10/2024 12:00:00 PM
- Lexicon Pharmaceuticals to Participate in Upcoming September Investor Conferences • GlobeNewswire Inc. • 09/03/2024 08:00:00 PM
- New Secondary Analysis of Phase 3 Data Demonstrates that INPEFA® (Sotagliflozin) Benefited Heart Failure Patients Regardless of Diabetes Duration • GlobeNewswire Inc. • 09/03/2024 12:00:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 08/16/2024 04:15:16 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/15/2024 08:47:50 PM
- Lexicon Pharmaceuticals Announces Strategic Repositioning to Drive Value and Growth of Commercial Portfolio • GlobeNewswire Inc. • 08/13/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/12/2024 12:40:16 PM
- Efficacy and Safety Data of Sotagliflozin in Patients with Type 1 Diabetes and Chronic Kidney Disease Among Three Lexicon-Sponsored Presentations at the 2024 Annual Conference of the Association of Diabetes Care & Education Specialists • GlobeNewswire Inc. • 08/07/2024 12:00:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 08/02/2024 01:37:54 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/02/2024 11:06:49 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 08:05:23 PM
- Lexicon Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 08/01/2024 08:00:00 PM
- Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 07/29/2024 09:44:55 PM
- Lexicon Pharmaceuticals to Host Second Quarter 2024 Financial Results Conference Call and Webcast on August 1, 2024 • GlobeNewswire Inc. • 07/25/2024 12:00:00 PM
- Lexicon Pharmaceuticals Receives December 20, 2024 PDUFA Goal Date for Sotagliflozin Type 1 Diabetes NDA Resubmission • GlobeNewswire Inc. • 07/16/2024 12:00:00 PM
- New Published Data Highlights Potential Cost-Savings of INPEFA® (sotagliflozin) for Heart Failure • GlobeNewswire Inc. • 07/15/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/08/2024 09:27:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/08/2024 09:27:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/08/2024 01:15:18 PM
- Lexicon Board of Directors Appoints Mike Exton, Ph.D. as New Chief Executive Officer and Director • GlobeNewswire Inc. • 07/08/2024 01:15:00 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM